Document text
Principal Investigator: Gregory L Brown
Organization: PENNSYLVANIA STATE UNIV HERSHEY MED CTR
Fiscal Year: 2024
Award: $34,585
Funding agency: National Institute on Aging
Due to an aging population and increased lifespan, dementia is an increasing clinical and public health issue. The most common and well-known cause is Alzheimer’s disease (AD), but other important disorders are involved in the development of AD-related dementias (ADRD). What is less appreciated is that Parkinson’s disease (PD), the second most common neurodegenerative disease, while often associated with motor dysfunction, contributes to ADRD with an incidence of dementia as high as 80% in late stages in which most have AD co-pathology. Therefore, this population exhibits a range of cognitive deficits that enables insight into mechanisms involved in ADRD. There seem to be two distinct cognitive profiles in these patients. One is a benign frontal profile characterized by executive and attention deficits, whereas the other is a posterior profile characterized by memory and visuospatial deficits that is associated with faster progression to dementia, often with AD co-pathology. The premise of this application is that identifying the neural circuitry underlying frontal and posterior function may provide insight into structural alterations occurring in ADRD. Dopaminergic therapies are known to improve frontal circuitry function, but not posterior circuitry, leading to the hypothesis that posterior circuit alterations are due to non-dopaminergic pathology, such as AD co-pathology. If true, the pattern of frontal-vs-posterior involvement may lead to differential responses to current treatments in ADRD. I plan to apply diffusion tensor tractography, a sensitive and widely available MRI technique, to measure microstructural integrity of white matter (WM) connections between brain regions. My central hypothesis is that WM alterations in frontal and posterior circuitry occurs in PD (Aim 1); that these alterations are associated with specific cognitive deficits and relate to differing rates of progression to dementia (Aim 2); and the ratio of frontal to posterior damage (F/P ratio) modulates the cognitive response to treatment (e.g., levodopa, deep brain stimulation, Aim 3). These aims will be implemented by leveraging existing datasets allowing a cost-effective and impactful investigation. This study immediately will impact knowledge of WM circuits related to dementia with insight into underlying mechanisms and therapeutic strategies, as well as provide the foundational line of research for future study of microstructural signatures of AD/ADRD. I have assembled a world-class mentoring team with expertise in areas related to my research and a history of highly-successful mentoring. The environment and institutional resources available to me for this project are excellent with a well-developed training plan and access to required equipment and research datasets. The proposed project and training plan will position me at the intersection of neuroscience and engineering, and enable me to tackle important clinical problems with the latest technological advancements. My new skills in neuroimaging analysis and neuropsychological testing to probe neurocognitive circuitry will provide a foundation for my career as an independent physician-engineer focused on alleviating the burden of AD/ADRD.
Terms: <AD dementia><AD related dementia><ADRD><Accounting><Active Follow-up><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Amentia><Ammon Horn><Area><Attention><Attentional deficit><Basal Ganglia><Basal Nuclei><Benign><Brain><Brain Nervous System><Brain region><Clinical><Cognition><Cognition Therapy><Cognitive><Cognitive Disturbance><Cognitive Impairment><Cognitive Psychotherapy><Cognitive Therapy><Cognitive decline><Cognitive deficits><Cognitive function abnormal><Cognitive treatment><Cornu Ammonis><Corpus Striatum><Corpus striatum structure><Data><Data Set><Dedications><Deep Brain Stimulation><Degenerative Neurologic Disorders><Dementia><Development><Diffusion><Digit><Digit structure><Disease><Disorder><Disturbance in cognition><Drugs><Dysfunction><Encephalon><Engineering><Environment><Equipment><Exhibits><Extracellular Space><Fiber><Foundations><Functional disorder><Future><Hippocampus><History><Hydrogen Oxide><Immediate Memory><Impaired cognition><Incidence><Increase lifespan><Institution><Intercellular Space><Investigation><Knowledge><L-Dopa><Levodopa><Long-term cohort><Longitudinal cohort><Longterm cohort><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Measures><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Medication><Memory><Mentors><NMR Imaging><NMR Tomography><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurocognitive><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><Neuropsychologic Tests><Neuropsychological Tests><Neurosciences><Nuclear Magnetic Resonance Imaging><Outcome><Paralysis Agitans><Parietal><Parkinson><Parkinson Disease><Pathology><Patients><Pattern><Pharmaceutical Preparations><Physicians><Physiopathology><Play><Population><Position><Positioning Attribute><Primary Parkinsonism><Primary Senile Degenerative Dementia><Process><Prognosis><Public Health><Recording of previous events><Research><Research Resources><Research Subjects><Resources><Role><Short-Term Memory><Shortterm Memory><Striate Body><Striatum><Syndrome><Techniques><Technology><Testing><Therapeutic><Training><Treatment outcome><Visuospatial><Water><Zeugmatography><active followup><aged group><aged groups><aged individual><aged individuals><aged people><aged person><aged persons><aged population><aged populations><aging population><attentive deficit><career><cognitive behavior intervention><cognitive behavior modification><cognitive behavior therapy><cognitive behavioral intervention><cognitive behavioral modification><cognitive behavioral therapy><cognitive behavioral treatment><cognitive change><cognitive defects><cognitive dysfunction><cognitive function><cognitive loss><cognitive performance><cohort><cost effective><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><demented><dementia risk><developmental><diffused><diffuses><diffusing><diffusions><drug/agent><elongating the lifespan><extend life span><extend lifespan><follow up><follow-up><followed up><followup><global health><healthy aging><healthy human aging><hippocampal><histories><improved><insight><lifespan extension><memory recall><motor disease><motor disorder><motor dysfunction><neural><neural circuit><neural circuitry><neural imaging><neuro-imaging><neurocircuitry><neurodegenerative illness><neuroimaging><neurological imaging><novel><pathophysiology><patient profile><population aging><primary degenerative dementia><profiles in patients><progression biomarker><progression marker><response><response to therapy><response to treatment><risk factor for dementia><risk for dementia><senile dementia of the Alzheimer type><skills><social role><striatal><substantia alba><synaptic circuit><synaptic circuitry><therapeutic response><therapy response><tractography><treatment response><treatment responsiveness><treatment strategy><visual spatial><white matter><white matter damage><working memory>